AU4895390A - Use of certain gamma interferons in the preparation of pharmaceutical compositions intended for the treatment of cancer of the ovary by intra-peritoneal route - Google Patents

Use of certain gamma interferons in the preparation of pharmaceutical compositions intended for the treatment of cancer of the ovary by intra-peritoneal route

Info

Publication number
AU4895390A
AU4895390A AU48953/90A AU4895390A AU4895390A AU 4895390 A AU4895390 A AU 4895390A AU 48953/90 A AU48953/90 A AU 48953/90A AU 4895390 A AU4895390 A AU 4895390A AU 4895390 A AU4895390 A AU 4895390A
Authority
AU
Australia
Prior art keywords
cancer
ovary
intra
treatment
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU48953/90A
Other versions
AU632528B2 (en
Inventor
Maud Brandely
Danielle Lando
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9378406&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU4895390(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of AU4895390A publication Critical patent/AU4895390A/en
Application granted granted Critical
Publication of AU632528B2 publication Critical patent/AU632528B2/en
Assigned to HOECHST MARION ROUSSEL reassignment HOECHST MARION ROUSSEL Alteration of Name(s) in Register under S187 Assignors: ROUSSEL-UCLAF
Assigned to AVENTIS PHARMA S.A. reassignment AVENTIS PHARMA S.A. Alteration of Name(s) in Register under S187 Assignors: HOECHST MARION ROUSSEL
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Use of a recombinant polypeptide having an activity of the human gamma-interferon type for preparing a pharmaceutical composition which can be administered intraperitoneally in perfusion and is intended for the effective treatment of ovarian cancer.
AU48953/90A 1989-02-02 1990-02-01 Use of certain gamma interferons in the preparation of pharmaceutical compositions intended for the treatment of cancer of the ovary by intra-peritoneal route Expired AU632528B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8901346A FR2644067B1 (en) 1989-02-02 1989-02-02 USE OF CERTAIN GAMMA INTERFERONS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OVARY CANCER BY THE INTRAPERITONEAL ROUTE
FR8901346 1989-02-02

Publications (2)

Publication Number Publication Date
AU4895390A true AU4895390A (en) 1990-08-09
AU632528B2 AU632528B2 (en) 1993-01-07

Family

ID=9378406

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48953/90A Expired AU632528B2 (en) 1989-02-02 1990-02-01 Use of certain gamma interferons in the preparation of pharmaceutical compositions intended for the treatment of cancer of the ovary by intra-peritoneal route

Country Status (12)

Country Link
EP (1) EP0381584B1 (en)
JP (1) JPH0772137B2 (en)
KR (1) KR100203316B1 (en)
AT (1) ATE99954T1 (en)
AU (1) AU632528B2 (en)
CA (1) CA2009106A1 (en)
DE (1) DE69005837T2 (en)
DK (1) DK0381584T3 (en)
FR (1) FR2644067B1 (en)
HU (1) HU204711B (en)
OA (1) OA09191A (en)
ZA (1) ZA90671B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
WO1987005518A1 (en) * 1986-03-17 1987-09-24 Schering Corporation Treatment of cancers with gamma interferon

Also Published As

Publication number Publication date
HU900202D0 (en) 1990-03-28
JPH02235818A (en) 1990-09-18
EP0381584B1 (en) 1994-01-12
CA2009106A1 (en) 1990-08-02
DE69005837D1 (en) 1994-02-24
JPH0772137B2 (en) 1995-08-02
KR900012628A (en) 1990-09-01
EP0381584A3 (en) 1991-11-06
OA09191A (en) 1992-06-30
ATE99954T1 (en) 1994-01-15
ZA90671B (en) 1991-04-24
AU632528B2 (en) 1993-01-07
HU204711B (en) 1992-02-28
EP0381584A2 (en) 1990-08-08
HUT54302A (en) 1991-02-28
FR2644067B1 (en) 1993-02-05
DE69005837T2 (en) 1994-05-11
FR2644067A1 (en) 1990-09-14
KR100203316B1 (en) 1999-06-15
DK0381584T3 (en) 1994-02-14

Similar Documents

Publication Publication Date Title
IL87621A0 (en) Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them
DE68909267T2 (en) Drug for the treatment of fibrotic disorder and antifibrotic compound.
DE3773295D1 (en) HOMOGENEOUS RECOMBINANT IMMUNE INTERFERON FRAGMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ZA904353B (en) Use of a polypeptide having the activity of human interleukin 2 for preparing a pharmaceutical composition intended for the treatment of primary cancers of the pleura
NO863027D0 (en) PEPTID PREPARATIONS WITH CONTINUOUS DELIVERY.
AU4895390A (en) Use of certain gamma interferons in the preparation of pharmaceutical compositions intended for the treatment of cancer of the ovary by intra-peritoneal route
IE871358L (en) Interferon for carcinoma
DE3869789D1 (en) TREATMENT OF SOME LEUKAEMIA WITH A COMPOSITION OF INTERFERON-GAMMA AND INTERFERON-ALPHA.
ATE92333T1 (en) MEDICATIONS FOR THE INTRALESION TREATMENT OF SCALP-LIKE CELL CARCINOMA WITH RECOMBINANT HUMAN ALPHA INTERFERON.
AU609435B2 (en) Prevention of bovine respiratory disease complex in cattle by administration of interferon
DK0427633T3 (en) Use of a polypeptide with gamma interferon activity for the preparation of pharmaceutical preparations intended for the treatment of primitive pleural cancer
KR920014480A (en) Use of a polypeptide having activity of human interleukin 2 to prepare a pharmaceutical composition for treating pneumothorax

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: AVENTIS PHARMA S.A.

Free format text: FORMER OWNER WAS: HOECHST MARION ROUSSEL